Preloader

Label-free photothermal disruption of cytotoxic aggregates rescues pathology in a C. elegans model of Huntington’s disease

  • 1.

    Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45–51 (2013).

    ADS 
    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 2.

    Ehrnhoefer, D. E., Wong, B. K. & Hayden, M. R. Convergent pathogenic pathways in Alzheimer’s and Huntington’s diseases: Shared targets for drug development. Nat. Rev. Drug Discov. 10, 853–867 (2011).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 3.

    Ayyadevara, S. et al. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer’s hippocampus from normal controls. Aging Cell 15, 924–939 (2016).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 4.

    Aguzzi, A. & O’Connor, T. Protein aggregation diseases: Pathogenicity and therapeutic perspectives. Nat. Rev. Drug Discov. 9, 237–248 (2010).

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 5.

    Tyedmers, J., Mogk, A. & Bukau, B. Cellular strategies for controlling protein aggregation. Nat. Rev. Mol. Cell Biol. 11, 777–788 (2010).

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 6.

    Gil, J. M. & Rego, A. C. Mechanisms of neurodegeneration in Huntington’s disease. Eur. J. Neurosci. 27, 2803–2820 (2008).

    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 7.

    Ayyadevara, S. et al. Aspirin-mediated acetylation protects against multiple neurodegenerative pathologies by impeding protein aggregation. Antiox. Redox. Signal 27, 1383–1396 (2017).

    CAS 
    Article 

    Google Scholar 

  • 8.

    Kiaei, M. et al. ALS-causing mutations in profilin-1 alter its conformational dynamics: A computational approach to explain propensity for aggregation. Sci. Rep. 8, 13102 (2018).

    ADS 
    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar 

  • 9.

    Bersuker, K., Hipp, M., Calamini, B., Morimoto, R. I. & Kopito, R. R. Heat shock response activation exacerbates inclusion body formation in a cellular model of Huntington disease. J. Biol. Chem. 288, 23633–23638 (2013).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 10.

    Ayyadevara, S. et al. Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes. Aging Cell 14, 35–48 (2015).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 11.

    Jia, K., Hart, A. C. & Levine, B. Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans. Autophagy 3, 21–25 (2007).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 12.

    Olzscha, H. et al. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67–78 (2011).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 13.

    Jiang, H., Nucifora, F. C., Ross, C. A. & DeFranco, D. B. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet. 12, 1–12 (2003).

    PubMed 
    Article 

    Google Scholar 

  • 14.

    Ross, C. A. & Tabrizi, S. J. Huntington’s disease: From molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83–98 (2011).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 15.

    Arrasate, M. & Finkbeiner, S. Protein aggregates in Huntington’s disease. Exp. Neurol. 238, 1–11 (2012).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 16.

    Truant, R., Atwal, R. S., Desmond, C., Munsie, L. & Tran, T. Huntington’s disease: Revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases. FEBS J. 275, 4252–4262 (2008).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 17.

    Chen, S., Ferrone, F. A. & Wetzel, R. Huntington’s disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA 99, 11884–11889 (2002).

    ADS 
    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 18.

    Thakur, A. K. et al. Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16, 380–389 (2009).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 19.

    Rub, U. et al. Huntington’s disease (HD): Degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol. 24, 247–260 (2014).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 20.

    Strong, T. V. et al. Widespread expression of the human and rat Huntington’s disease gene in brain and nonneural tissues. Nat. Genet. 5, 259–265 (1993).

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 21.

    Morley, J. F., Brignull, H. R., Weyers, J. J. & Morimoto, R. I. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 99, 10417–10422 (2002).

    ADS 
    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar 

  • 22.

    Gidalevitz, T., Wang, N., Deravaj, T., Alexander-Floyd, J. & Morimoto, R. I. Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease. BMC Biol. 11, 100 (2013).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar 

  • 23.

    Zhang, H. R. et al. Inhibition of polyglutamine-mediated proteotoxicity by A. membranaceus polysaccharide through the DAF-16/FOXO transcription factor in Caenorhabditis elegans. Biochem. J. 441, 417–424 (2012).

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 24.

    Shin, B. H. et al. Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy. PLoS One 8, 2 (2013).

    Google Scholar 

  • 25.

    Burks, T. N. & Cohn, R. D. One size may not fit all: Anti-aging therapies and sarcopenia. Aging 3, 1142–1153 (2011).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 26.

    Joshi, A. S. & Thakur, A. K. Biodegradable delivery system containing a peptide inhibitor of polyglutamine aggregation: A step toward therapeutic development in Huntington’s disease. J. Pept. Sci. 20, 630–639 (2014).

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 27.

    Yu, S., Liang, Y., Palacino, J., Difiglia, M. & Lu, B. Drugging unconventional targets: Insights from Huntington’s disease. Trends Pharmacol. Sci. 35, 53–62 (2014).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Scholar 

  • 28.

    Letokhov, V. Laser biology and medicine. Nature 316, 325–330. https://doi.org/10.1038/316325a0 (1985).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • 29.

    Zharov, V., Galitovsky, V. & Viegas, M. Photothermal detection of local thermal effects during selective nanophotothermolysis. Appl. Phys. Lett. 83, 4897–4899 (2003).

    ADS 
    CAS 
    Article 

    Google Scholar 

  • 30.

    Hirsch, L. R. et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100, 13549–13554 (2003).

    ADS 
    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 31.

    Khlebtsov, B. N., Zharov, V. P., Melnikov, A. G., Tuchin, V. V. & Khlebtsov, N. G. Optical amplification of photothermal therapy with gold nanoparticles and nanoclusters. Nanotechnology 17, 5167–5179. https://doi.org/10.1088/0957-4484/17/20/022 (2006).

    ADS 
    CAS 
    Article 

    Google Scholar 

  • 32.

    Galanzha, E. I. et al. In vivo liquid biopsy using Cytophone platform for label-free photoacoustic detection of circulating tumor cells in melanoma patients. Sci. Transl. Med. 11, 496. https://doi.org/10.1126/scitranslmed.aat5857 (2019).

    CAS 
    Article 

    Google Scholar 

  • 33.

    Zharov, V. P., Kim, J.-W., Everts, M. & Curiel, D. T. Self-assembling nanoclusters in living systems: Application for integrated photothermal nanodiagnostics and nanotherapy (review). J. Nanomed. 1, 326–345 (2005).

    CAS 
    Article 

    Google Scholar 

  • 34.

    Nedosekin, D. A., Galanzha, E. I., Ayyadevara, S., Shmookler Reis, R. J. & Zharov, V. P. Photothermal confocal spectromicroscopy of multiple cellular chromophores and fluorophores. Biophys. J. 102, 672–681 (2012).

    ADS 
    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 35.

    Zharov, V. P. Ultrasharp nonlinear photothermal and photoacoustic resonances and holes beyond the spectral limit. Nat. Photon. 5, 110–116 (2011).

    ADS 
    CAS 
    Article 

    Google Scholar 

  • 36.

    Nedosekin, D. A., Galanzha, E. I., Dervishi, E., Biris, A. S. & Zharov, V. P. Super-resolution nonlinear photothermal microscopy. Small 10, 135–142 (2014).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 37.

    Brignull, H. R., Moore, F. E., Tang, S. J. & Morimoto, R. I. Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J. Neurosci. 26, 7597–7606 (2006).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 38.

    Lublin, A. L. & Link, C. D. Alzheimer’s disease drug discovery: In vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity. Drug Discov. Today Technol. 10, e115-119 (2013).

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • 39.

    Liachko, N. F., Guthrie, C. R. & Kraemer, B. C. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J. Neurosci. 30, 16208–16219 (2010).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 40.

    McCormick, A. V., Wheeler, J. M., Guthrie, C. R., Liachko, N. F. & Kraemer, B. C. Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity. Biol. Psychiatry 73, 464–471 (2013).

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 41.

    Kakraba, S. et al. A novel microtubule-binding drug attenuates and reverses protein aggregation in animal models of Alzheimer’s Disease. Front. Mol. Neurosci. 12, 310 (2019).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • 42.

    Ayyadevara, S., Ganne, A., Balasubramaniam, M., & Shmookler Reis, R. J. Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration. Metab. Brain Dis. (2021) (in press).

  • 43.

    Zharov, V. P., Mercer, K. E., Galitovskaya, E. N. & Smeltzer, M. S. Photothermal nanotherapeutics and nanodiagnostics for killing of bacteria targeted with nanoparticles. Biophys. J. 90, 619–627 (2006).

    ADS 
    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 44.

    Foster, F. R. et al. Photoacoustically-guided photothermal killing of mosquitoes targeted by nanoparticles. J. Biophoton. 7, 465–473 (2014).

    CAS 
    Article 

    Google Scholar 

  • 45.

    Cai, C. et al. In vivo photoacoustic flow cytometry for early malaria diagnosis. Cytometry A 89, 531–542 (2016).

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar 

  • 46.

    Shao, J. et al. Photothermal nanodrugs: Potential of TNF-gold nanospheres for cancer theranostics. Sci. Rep. 3, 1293 (2013).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar 

  • Source link